The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis

The researchers investigated whether regular exercise training affects the resting concentrations of Brain-Derived Neurotrophic Factor (BDNF) in peripheral blood. BDNF is a protein crucial for the growth, differentiation, and survival of neurons, and is hypothesized to mediate some of the cognitive and mood benefits of physical activity.

The study specifically compared:

**Intervention:** Exercise training programs lasting at least two weeks.

**Comparators:** The primary comparison was between pre- and post-intervention BDNF levels within the same individuals. They also conducted subgroup analyses to compare different types of exercise (aerobic vs. resistance training).

**Outcome measure:** Resting concentrations of BDNF in peripheral blood (measured in serum, plasma, or whole blood). "Resting" means the measurement was taken after a period of rest, not immediately after an exercise session, to reflect baseline levels.

This meta-analysis synthesized data from 29 individual studies, encompassing a total of **910 participants**.

The population characteristics across these studies were:

**Sex:** 61.3% male.

**Age:** Mean age of 42.2 years, with a wide standard deviation of ± 22.4 years, indicating a broad age range across the included studies.

**BMI:** Mean Body Mass Index (BMI) of 25.8 ± 2.3 kg/m², which falls into the overweight category, though individual studies would have varied.

**Health Status:** All included studies focused on **healthy adults**. Studies involving populations with diagnosed diseases (e.g., diabetes, Parkinson's disease, multiple sclerosis), psychiatric disorders (e.g., depression, schizophrenia), or children under 18 years of age were explicitly excluded.

**Setting:** The studies were conducted in various research settings globally, as is typical for a meta-analysis drawing from diverse published literature.

The individual studies ranged in size from 7 to 304 participants.

The primary outcome, peripheral blood BDNF concentration, was measured using various laboratory assays from different blood components:

**Blood Components:** BDNF was measured in either **serum, plasma, or whole blood**. The researchers noted that there can be variability in absolute BDNF concentrations between assays used by different laboratories and between these different blood components.

**Units:** BDNF concentrations were typically reported in **picograms per millilitre (pg/mL)**.

**Standardization:** To account for the variability in absolute BDNF values across different studies and measurement methods, the researchers used **Standardized Mean Differences (SMDs)**. This statistical approach converts the effect size from each study into a common, unitless metric, allowing for meaningful comparison and pooling of results. An SMD represents the difference in means between two groups (or pre/post intervention) divided by the pooled standard deviation, effectively expressing the effect in terms of standard deviation units.

This study was a **meta-analysis**, a systematic statistical approach to combine the results of multiple independent studies addressing a similar research question. This design is considered high-level evidence because it increases statistical power and generalizability compared to individual studies.

Here's how they conducted the meta-analysis and why this design matters:

**Data Sources and Search Strategy:**

* The researchers followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a standard for transparent and comprehensive reporting of systematic reviews and meta-analyses.

* They systematically searched six major English-language scientific databases up to February 2016: MEDLINE, Embase, PsycINFO, SPORTDiscus, Rehabilitation & Sports Medicine Source, and Cumulated Index to Nursing and Allied Health Literature (CINAHL). This comprehensive search aimed to minimize publication bias by including as much relevant literature as possible. They also checked reference lists of retrieved articles for additional studies. One non-English study was included with the help of a translator.

**Study Selection Criteria:**

* **Inclusion Criteria:** Studies had to meet specific requirements to be included:

1. Measured BDNF concentration in serum, plasma, or whole blood.

2. Measured BDNF both before and after an exercise intervention.

3. The exercise intervention lasted at least 2 weeks.

4. Exercise intensity was at least 50% of peak oxygen uptake (VO2Peak), or if intensity wasn't reported, the exercise was described as running, cycling, or resistance training (implying sufficient intensity).

* **Exclusion Criteria:** Studies were excluded if they:

1. Included a diseased population (e.g., diabetes, Parkinson's, MS) or a psychiatric population (e.g., depression, schizophrenia), as these conditions can alter BDNF levels and potentially modify the effect of exercise.

2. Included children below the age of 18.

3. Had significant co-interventions likely to impact BDNF (e.g., military training, restricted sleep).

4. Lacked extractable data (e.g., standard deviation not reported) or had exercise intensity below 50% VO2Peak (e.g., yoga or easy walking).

* **Process:** Two independent raters screened each article for eligibility. Any disagreements were resolved by consensus with a third rater. This dual-reviewer process helps reduce bias in study selection.

**Data Extraction:**

* Two independent raters extracted data into a pre-formatted spreadsheet. This included pre- and post-intervention mean BDNF concentrations and standard deviations, population characteristics (e.g., age, sex), exercise intervention characteristics (e.g., type, duration, frequency, intensity), and items related to the risk of bias.

* Missing data were requested from corresponding authors of the original studies.

* Exercise intensity prescriptions (e.g., percentage of maximum heart rate) were converted to a standardized measure (percentage of maximum VO2Peak) for consistency.

* For studies with multiple exercise groups, groups were combined for the overall analysis. Studies were also categorized as primarily aerobic or resistance training. If an intervention combined both, it was categorized based on where >50% of the time was spent.

**Statistical Approach:**

* **Standardized Mean Differences (SMDs):** As mentioned, SMDs were calculated to combine results from studies using different BDNF assays and blood components.

* **Random-Effects Models:** These models were used to generate SMDs and 95% confidence intervals (CI). Random-effects models are preferred when significant heterogeneity (variability) is expected across studies, as they account for both within-study and between-study variance. This is crucial because it assumes that the true effect size might vary from study to study, rather than assuming a single true effect.

* **Heterogeneity Assessment:** The researchers used Q statistics (from Chi-square analysis) and I² indices to quantify the inconsistency among study results. An I² value indicates the percentage of total variation across studies that is due to true heterogeneity rather than chance. High I